NeuroMetrix, Inc.

The momentum for this stock is not very good. NeuroMetrix, Inc. is not a good value stock. NeuroMetrix, Inc. is not a good growth stock. NeuroMetrix, Inc. is a mediocre stock to choose.
Log in to see more information.
NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of...
NURO Fundamental Data by TradingView

News

NeuroMetrix (NASDAQ:NURO) Receives New Coverage from Analysts at StockNews.com
NeuroMetrix (NASDAQ:NURO) Receives New Coverage from Analysts at StockNews.com

Ticker Report StockNews.com initiated coverage on shares of NeuroMetrix (NASDAQ:NURO - Free Report) in a report issued on Monday morning. The brokerage issued a sell rating on the medical device company's stock...\n more…

NeuroMetrix (NASDAQ:NURO) Coverage Initiated by Analysts at StockNews.com
NeuroMetrix (NASDAQ:NURO) Coverage Initiated by Analysts at StockNews.com

Ticker Report StockNews.com began coverage on shares of NeuroMetrix (NASDAQ:NURO - Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the medical device company's...\n more…

NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com
NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com

Zolmax StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO - Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a "sell" rating on the...\n more…

NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com
NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com

Ticker Report Research analysts at StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO - Get Free Report) in a note issued to investors on Saturday. The brokerage set a "sell" rating on the...\n more…

NeuroMetrix Reiterates its Review of Strategic Alternatives
NeuroMetrix Reiterates its Review of Strategic Alternatives

Globe Newswire WOBURN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today for the purpose of clarity, reiterated that the Company is engaged in a review of strategic alternatives. In...\n more…

NeuroMetrix (NASDAQ:NURO) Coverage Initiated at StockNews.com
NeuroMetrix (NASDAQ:NURO) Coverage Initiated at StockNews.com

Ticker Report StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO - Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a "sell" rating on the medical...\n more…